Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-01-27

Clinical Trial Update: Efficacy of Somatropin in Adult Patients With Isolated Growth Hormone Deficiency [Phase 3]

View source ↗

Summary

Pfizer-sponsored Phase 3 trial evaluating somatropin in adults with isolated growth hormone deficiency has terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GENOTROPIN (SOMATROPIN)
  • Somatropin (somatropin)

Snippet

Sponsor: Pfizer | Conditions: Growth Hormone Deficiency | Phase 3 | Status: TERMINATED | Results posted: 2011-01-27